4
Changes in Ownership
Sionna Therapeutics, Inc. Filed Acc 0000950170-25-017034
Options or other derivatives
- President & CEO acquired 450,252 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Cloonan Michael President & CEO | 2025-02-06 | Grant or award · Stock Option (Right to Buy) | +450,252 | 450,252 | D | ||
Loading xslF345X05/ownership.xml…